Jian Xin Yang
Chief Executive Officer chez CSTONE PHARMACEUTICALS
Fortune : 2 M $ au 31/03/2024
Postes actifs de Jian Xin Yang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CSTONE PHARMACEUTICALS | Director/Board Member | 25/08/2022 | - |
| Chief Executive Officer | 25/08/2022 | - | |
| Chief Tech/Sci/R&D Officer | 01/12/2016 | 25/08/2022 |
Historique de carrière de Jian Xin Yang
Anciens postes connus de Jian Xin Yang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BEIGENE, LTD. | Chief Tech/Sci/R&D Officer | 01/07/2014 | 01/12/2016 |
| COVANCE INC. | Chief Tech/Sci/R&D Officer | 01/09/2011 | 01/07/2014 |
Formation de Jian Xin Yang
| Nanjing Medical University | Graduate Degree |
| Hubei University of Science & Technology | Undergraduate Degree |
Statistiques
Internationale
| Chine | 4 |
| Etats-Unis | 2 |
| Îles Cayman | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BEIGENE, LTD. | Health Technology |
| CSTONE PHARMACEUTICALS | Health Technology |
| Entreprise privées | 1 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
- Bourse
- Insiders
- Jian Xin Yang
- Expérience
